Rehmann Capital Advisory Group’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$111K Sell
4,615
-25,970
-85% -$691K 0.01% 423
2019
Q2
$872K Buy
30,585
+24,209
+380% +$605K 0.11% 152
2019
Q1
$160K Sell
6,376
-10,402
-62% -$199K 0.02% 462
2018
Q4
$211K Buy
+16,778
New +$198K 0.03% 242

Other funds holding VCYT

Rehmann Capital Advisory Group's VCYT Position: Q3 2019 in Review

Rehmann Capital Advisory Group reduced its Veracyte (VCYT) stake by 85% in Q3 2019, selling an estimated $691K and leaving 4,615 shares worth $111K. The position accounts for 0.01% of the portfolio, ranked #423.

Rehmann Capital Advisory Group first reported a position in VCYT in Q4 2018 and has held it in 4 quarters since. The position peaked at $872K in Q2 2019. 187 funds tracked by Wall St. Rank hold VCYT as of Q3 2019.

  • Rehmann Capital Advisory Group held 4,615 shares of Veracyte worth $111K as of Q3 2019.
  • Rehmann Capital Advisory Group sold 25,970 Veracyte shares in Q3 2019, an estimated $691K.
  • Veracyte made up 0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #423 holding.
  • Rehmann Capital Advisory Group first reported a position in Veracyte in Q4 2018 and has held it in 4 quarters since.
  • Rehmann Capital Advisory Group's Veracyte position peaked at $872K in Q2 2019.
  • 187 funds tracked by Wall St. Rank held Veracyte as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.